Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/4/24 18:09 | 6/3/24 | VOR | Health | BioPrd | Biological Products, (No Diag | Attar Eyal C. | MA | O | Chief Me | S | -20 | 1.39 | 0 | -15 | -13 | 96 | D | ||||||||||||||
11/18/21 20:14 | 11/16/21 | VOR | Health | BioPrd | Biological Products, (No Diag | 5Am Ventures Vi, L.P. | CA | T | S | -5,060 | 15.30 | 0 | -331 | -16 | 1,767 | I | |||||||||||||||
11/18/21 20:10 | 11/16/21 | VOR | Health | BioPrd | Biological Products, (No Diag | Parmar Kush | MA | DT | S | -5,060 | 15.30 | 0 | -331 | -16 | 1,767 | I | |||||||||||||||
8/19/21 16:02 | 8/17/21 | VOR | Health | BioPrd | Biological Products, (No Diag | Chakraborty Tirtha | MA | O | Chief Sc | M.d | 24 | 1.36 | 0 | 17 | 494 | 21 | D | ||||||||||||||
2/9/21 18:25 | 2/9/21 | VOR | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | P.d | 53,632 | 18.00 | 0 | 2,980 | 1,825 | I | ||||||||||||||||
2/9/21 18:03 | 2/9/21 | VOR | Health | BioPrd | Biological Products, (No Diag | 5Am Ventures Vi, L.P. | CA | T | P.d | 10,000 | 18.00 | 0 | 556 | 43 | 1,858 | I | |||||||||||||||
2/9/21 17:15 | 2/9/21 | VOR | Health | BioPrd | Biological Products, (No Diag | Parmar Kush | MA | DT | P.d | 10,000 | 18.00 | 0 | 556 | 43 | 1,858 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |